Assistant de consignation de l’indice fonctionnel ECOG

État

clinical-review-pending

Version de la méthode

Oken et al. official 1982 ECOG Performance Status Scale documentation contract, engine ecog-performance-status-1982-documentation-v1: this helper records, but never calculates, derives, converts, recommends, or imputes, one qualified oncology clinician-selected grade from the complete official English descriptors at one identified assessment timepoint. A living assessment accepts only grade 0, 1, 2, 3, or 4; grade 5 means Dead and is accepted only through the separate death-already-documented branch after independent verification of an authoritative clinical death record. Grade 4 is never treated as death. Exactly 50% of waking hours and any borderline or discordant descriptor fit remain clinician judgments; work in the source descriptors means functional capacity, not employment status. Four common confirmations are required: adult oncology documentation scope; selection of the official 1982 scale; one documented assessment or death-record timepoint; and acknowledgement of subjectivity, cause non-differentiation, and documentation-only limitations. A living assessment additionally requires five independent confirmations: qualified-clinician selection; review of the complete descriptor domains without a single-metric shortcut; no algorithmic derivation, Karnofsky conversion, or imputation; review of potential causes, confounders, and support context without automatic adjustment; and clinician resolution of borderline or discordant fit. The death-record branch instead requires two independent confirmations: verification of the authoritative clinical death record; and acknowledgement that grade 5 means death only and was not inferred from living function. Output is limited to version, the unchanged grade, its exact official English descriptor, and the entered branch/timepoint/grade/identity audit; no classification, conversion, diagnosis, eligibility determination, prognosis, outcome estimate, treatment, dosing, disposition, management, or recommendation is supplied.

Population

Qualified oncology clinicians documenting one directly selected ECOG Performance Status Scale grade for an adult in an oncology context at one identified initial-oncology, pretreatment-baseline, on-treatment, post-treatment-follow-up, or other documented oncology assessment, or documenting grade 5 only from an independently verified authoritative clinical death record. The 1982 Oken publication presented standardized toxicity and response criteria for cancer clinical trials; it was not a reported derivation or validation study and provides no scale-development sample size, age cutoff, tumor-specific cohort, or recall window. Restriction to adults is this product's deliberately narrower policy, not an original ECOG source boundary. The complete official English descriptors remain authoritative; French text is convenience translation only.

Limites et exclusions

Pediatric grading; patient- or caregiver-selected grading; self-assessment; automatic chart abstraction; checklist, activity-question, waking-hours-percentage, employment-status, or single-metric classification; KPS, PPS, Lansky, or another performance-scale conversion; app resolution of exactly 50% of waking hours; cause attribution; or a missing, unknown, inferred, imputed, defaulted, carried-forward, mixed-timepoint, or algorithmically derived grade. · Grade 5 without an independently verified authoritative clinical death record, or inference of death from ECOG grade 4, complete disability, bed or chair confinement, hospice or palliative status, a moribund description, unresponsiveness, absent follow-up, or any other living functional observation. Grade 5 means death only. · Diagnosis; individual prognosis; survival or mortality estimation; outcome or toxicity prediction; trial inclusion or exclusion; treatment eligibility or fitness; treatment selection; dosing; disposition; monitoring; management; recommendation; or any care decision. · Presenting a French convenience translation as official; replacing or obscuring the exact official English descriptors; omitting the formal ECOG Performance Status Scale name above screen, print, or copied output or the full Oken citation and exact ECOG/ECOG-ACRIN credit line below it; reusing the journal article, ECOG-ACRIN logo, website design, colors, branding, or visual identity; or implying ECOG/ECOG-ACRIN endorsement. The scale-specific public-domain statement is not a software license.

• https://ecog-acrin.org/resources/ecog-performance-status/
• https://pubmed.ncbi.nlm.nih.gov/7165009/
• https://doi.org/10.1097/00000421-198212000-00014
• https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cancer-clinical-trial-eligibility-criteria-performance-status
• https://pubmed.ncbi.nlm.nih.gov/33563633/

Outil importé de la bibliothèque PharmaTek de MDose. Aucune date de révision clinique indépendante n’est documentée dans cette version.

Bibliothèque source

PharmaTek · MDose

Version importée

4b66536936ed

État de publication

Révision clinique en cours